Status:
UNKNOWN
Apelin in Willis Ekbom Disease
Lead Sponsor:
Acibadem University
Conditions:
Restless Legs Syndrome
Eligibility:
All Genders
18-55 years
Brief Summary
The purpose of this study is to assess apelin level in patients with Willis-Ekbom Disease (WED) as known Restless Legs Syndrome (RLS). Cardiovascular complications of WED have been reported in recent ...
Eligibility Criteria
Inclusion
- Patients diagnosed as RLS/WED according to International Classification of Sleep Disorders (ICSD-3) criteria
- Patients with idiopathic RLS/WED
- Moderate and severe RLS/WED according to International Restless Legs Syndrome Rating Scale
- Periodic Leg Movements Index above 5 in polysomnography record
- BMI below 25
Exclusion
- Disorders which cause symptomatic RLS(Iron deficiency anemia, kidney failure, diabetes mellitus, pregnancy, Parkinson's disease, multiple sclerosis, neuropathy)
- Systemic diseases which cause possible oxidative stress status (cardiovascular diseases, obesity, diabetes mellitus, use of any medical drugs especially ACE inhibitors e.g.)
- Another sleep disorder
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02264600
Start Date
November 1 2014
End Date
April 1 2015
Last Update
October 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.